These patients with acromegaly and hyperprolactinemia (adenomas secreting both hGH and hPRL) have significantly more severe menstrual disorders, galactorrhea, poorer surgical control, and higher adenoma relapse rates than GH-only pituitary adenoma patients (55). The gene discussed is GH1; the disease is hyperprolactinemia.